| Connected Entity | Relationship Type |
Strength
(mentions)
|
Documents | Actions |
|---|---|---|---|---|
|
person
Wa'el Jalaidan
|
Leadership |
5
|
1 | |
|
person
Masri
|
Alumnus |
1
|
1 |
| Date | Event Type | Description | Location | Actions |
|---|---|---|---|---|
| 2012-07-01 | N/A | Durata Therapeutics IPO | NASDAQ | View |
This document is Page 8 of 51 from Donald J. Trump's OGE Form 278e (Executive Branch Personnel Public Financial Disclosure Report). It lists positions held by Trump outside the US government in various entities (LLCs and Corporations), mostly based in New York and Las Vegas. The list includes entities related to hotels, development, marketing, and international branding (Asia, Baja, Batumi, Dubai, Egypt, Istanbul). The positions listed generally end on 1/19/2017, the day prior to his presidential inauguration. There is no mention of Jeffrey Epstein or Ghislaine Maxwell on this specific page.
This document is page 5 of 51 from Donald J. Trump's OGE Form 278e financial disclosure. It lists numerous positions held by Trump outside the U.S. government, primarily in 'THC' (Trump Hotel Collection) branded entities, 'The Trump Corporation,' and 'The Donald J. Trump Foundation.' The entries detail his roles (President, Chairman, Member) in entities based in New York, Brazil, China, Canada, and Ireland, with most positions ending on January 19, 2017, the day before his presidential inauguration.
This document is a page from a legal filing (2012 WL 257568) related to 9/11 terrorist attacks litigation, specifically detailing the financial infrastructure of al-Qaeda. It describes the interconnections between Osama bin Laden, various financial institutions (Al Shamal, Faisal Islamic Bank, Tadamon, Al Rajhi Bank), and individuals designated as terrorists or sponsors. It notably discusses the discovery of the 'Golden Chain' document in Bosnia, which identified major financial benefactors of al-Qaeda.
This document is a page from a 2012 legal opinion (In re: Terrorist Attacks on September 11, 2001) originating from a House Oversight Committee production. It details the interconnectivity between purported Islamic charities (MWL, IIRO, SJRC) and Al-Qaeda leadership, specifically outlining how charity officials appointed known terrorists like Wa'el Jelaidan and Mohammed Jamal Khalifa to positions of power to facilitate funding and logistics for attacks, including the 1993 WTC bombing and the Bojinka plot. While part of a dataset potentially reviewed in Epstein-related investigations (likely regarding foreign financing), the text itself focuses exclusively on Al-Qaeda financing and 9/11 litigation without mentioning Jeffrey Epstein.
This document is a page from a legal opinion (In re: TERRORIST ATTACKS ON SEPTEMBER 11, 2001) detailing the origins of al-Qaeda. It describes how Osama bin Laden and Abdullah Azzam established the organization from the infrastructure of the Afghan jihad, utilizing a financial network known as the 'Golden Chain' comprised of various Islamic charities. The text also outlines specific fatwas issued by Bin Laden between 1992 and 1998 declaring war on the United States. While the document bears a 'HOUSE_OVERSIGHT' Bates stamp, the content on this specific page relates entirely to terrorism financing and history, with no direct mention of Jeffrey Epstein.
This document is a confidential investment report page (marked House Oversight) detailing the track record of New Leaf Ventures (NLV) in the biopharmaceutical sector. It highlights their investment strategy, networking capabilities, and specific performance metrics (multiples on invested capital) for various portfolio companies across funds NLV-I, NLV-II, and Sprout Funds. The text lists specific exits and IPOs occurring between 2011 and 2013.
This document is page 33 of a confidential investment memorandum for a fund named 'New Leaf' (likely New Leaf Venture Partners). It details the fund's strategy regarding late-stage commercialization and small-cap public biotech companies, citing specific successful exits like Acadia Pharmaceuticals (2.5x) and InterCept Pharmaceuticals (3.2x), as well as a recapitalization of MEI Pharma. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was obtained during a congressional investigation, likely into financial networks connected to the broader Epstein inquiry.
This document is a page from a corporate prospectus or due diligence report (marked Confidential, House Oversight) detailing the professional biographies of three Managing Directors at New Leaf (presumably New Leaf Venture Partners): Jeani Delagardelle, Ron Hunt, and Vijay Lathi. All three were previously associated with Sprout Group. The document lists their educational backgrounds and extensive board memberships across various pharmaceutical and medical technology companies.
This document appears to be page 135 of a philosophical or scientific manuscript regarding consciousness, time, and physiology. It discusses Mircea Eliade's concepts of 'sacred time,' indigenous views on cyclical time, and compares disconnected states of mind to the four stages of anesthesia. A specific sentence regarding 'Healing by becoming another or renewed self' via 'phase transition medicine' is highlighted yellow. The document bears a House Oversight Bates stamp, indicating it was part of the production of documents related to the Jeffrey Epstein investigation.
This document appears to be a page from a House Oversight Committee file (likely an exhibit) containing an excerpt of an article or interview featuring a man named Masri. The text focuses on the urban planning and development of the Palestinian city of Rawabi, citing influences from Reston, Virginia, Cairo suburbs, and the Israeli city of Modi'in. It discusses the psychological impact on Palestinians seeing high-standard construction in their territory.
This document is Page 125 of a financial report produced by Ackrell Capital, LLC, titled 'Chapter VII Capital Markets for Cannabis Companies.' It contains a data table listing 'Over The Counter' cannabis stocks with market values greater than $25 million as of November 30, 2017. The table provides financial metrics such as stock price, market value, enterprise value, and revenue for numerous entities. The document bears the Bates stamp 'HOUSE_OVERSIGHT_024761', indicating it was part of a document production to the House Oversight Committee, likely related to investigations into financial records.
This document is page 124 of a 'Cannabis Investment Report' dated December 2017, produced by Ackrell Capital. It contains financial tables listing market data (stock price, market value, enterprise value, revenue, EBITDA) for various cannabis-related companies listed on Nasdaq, NYSE, and AMEX as of November 30, 2017. The document bears a 'HOUSE_OVERSIGHT_024760' stamp, indicating it is part of a larger production of documents to the House Oversight Committee.
This document is a confidential financial appendix (Appendix 1) labeled 'Listing of Investments by Fund' for New Leaf Ventures II, L.P., dated March 31, 2014. It details the financial performance of numerous healthcare, therapeutic, and diagnostic companies in the fund's portfolio, split into realized/partially realized and unrealized investments. The document bears a House Oversight Committee stamp and a confidential control number, indicating it is part of a congressional investigation.
This document is a printout of page 3 of 4 of an LA Times interview with Alan Trounson, dated May 29, 2013. Trounson discusses stem cell research, public perception, funding returns compared to the Human Genome Project, and conflict of interest issues at the California Institute for Regenerative Medicine (CIRM). The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a document production for a congressional investigation.
Page 2 of 4 of an LA Times interview with Alan Trounson (dated May 29, 2013) discussing the state of stem cell research in California. Trounson outlines plans to request $70 million from the CIRM board to establish a network of clinics and compares California's collaborative research environment (funded by Proposition 71's $3 billion) to the competitive environments of Harvard and Australia. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a congressional document production.
This document is a cover letter from Michael J. Boccio, likely sent to Jeffrey Epstein (based on external context of these files), seeking employment or a business relationship. Boccio leverages his three years of experience working directly under Donald Trump at the Trump Organization, highlighting his role in acquiring assets like jets and real estate, and managing licensing for the Ivanka Trump brand. The document bears a House Oversight Committee stamp.
This document appears to be a page of endnotes (numbered 68-80) from a book, likely Timothy Ferriss's 'The 4-Hour Workweek', stamped with a House Oversight identifier (HOUSE_OVERSIGHT_013979). The text contains advice on travel, business negotiation, outsourcing, and technology (SIM cards, email scanning), along with various URL references. While stamped as part of an oversight investigation (potentially related to the broader Epstein document dumps), the content itself is generic self-help and business advice with no direct mentions of Epstein, Maxwell, or illicit activities on this specific page.
This document is a page from 'The Shimon Post,' a Presidential News Bulletin dated May 29, 2011. It features a caricature of Shimon Peres playing soccer with Lionel Messi and lists five news articles from various outlets (NYT, NY Daily News, Al-Ahram Weekly, etc.) authored by individuals including Thomas L. Friedman and Alan Dershowitz. The document bears a 'HOUSE_OVERSIGHT_030268' footer, indicating it was part of a document production for a congressional investigation.
| Date | Type | From | To | Amount | Description | Actions |
|---|---|---|---|---|---|---|
| 2019-08-27 | Paid | A T | Motorola | $3,450,000,000.00 | Buyout of Motorola division. | View |
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein entity